TITLE

Paradoxical Response to the Vasodilators

AUTHOR(S)
Gould, Lawrence; Patel, S.; Gomes, G. I.; Reddy, C.V. R.
PUB. DATE
February 1982
SOURCE
Angiology;Feb1982, Vol. 33 Issue 2, p125
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
A 52-year-old male was admitted to the hospital in congestive heart failure. Mitral stenosis as well as an aortic valve prosthesis were the underlying cardiac abnormalities. A Swan-Ganz catheter was inserted and various vasodilators were administered. Phentolamine, nitrates, nitroprusside, and hydralazine all produced an unexpected and at times an alarming increase in the pulmonary artery pressure. The explanation for this paradoxical hemodynamic response is unknown but demonstrates the importance of hemodynamic monitoring with vasodilator therapy.
ACCESSION #
16372138

 

Related Articles

  • The role of vasodilators in the prevention and treatment of no-reflow following percutaneous coronary intervention. Harding, Scott A. // Heart;Sep2006, Vol. 92 Issue 9, p1191 

    The article discusses the function of vasodilators in averting and treatment of no-reflow following percutaneous coronary intervention. According to the author, the routine employment of vasodilators in patients with acute coronary syndromes and other percutaneous coronary intervention (PCI)...

  • STUDIES ON A NEW CORONARY VASODILATOR; l-CHLORO-2,3-PROPANEDIOL DINITRATE. Burgison, Raymond M.; Lu, Gordon G.; Cowley, R. Adams; Krantz Jr., John C. // Angiology;Sep1962, Vol. 13 Issue 9, p412 

    Focuses on the development of a new coronary vasodilator, 1-chloro-2,3-propanediol dinitrate, for the treatment of angina pectoris. Capacity of the compound to provide a longer duration of vasodilation with less concomitant side-effects; Materials and methods for the development of the new...

  • TREATMENT OF ANGINA PECTORIS WITH A NEW CORONARY VASODILATOR, ISOSORBIDE DINITRATE SUBLINGUAL (ISORDIL SUBLORAL). Smith Sr., Arthur L. // Angiology;Sep1962, Vol. 13 Issue 9, p425 

    Focuses on the use of the coronary vasodilator, isosorbide dinitrate sublingual, for treatment of angina pectoris. Clinical features of angina pectoris; Safety and efficacy of the drug; Recommended dosage for oral isosorbide dinitrate treatment.

  • isosorbide dinitrate.  // Royal Society of Medicine: Medicines;2002, p311 

    The article presents information on isosorbide dinitrate, a short-acting vasodilator and anti-angina drug. It is used to prevent attacks of angina pectoris (ischaemic heart pain), for instance when taken before exercise for symptomatic relief during an acute attack, and as an adjunct (to aid and...

  • Angeze SR.  // Royal Society of Medicine: Medicines;2002, p61 

    The article provides information on Angeze SR, is a proprietary, prescription-only preparation of the vasodilator drug isosorbide mononitrate. It can be used as an anti-angina drug, and is available as capsules.

  • A COMPARATIVE STUDY OF VASCULAR RESPONSES TO THE INTRA-ARTERIAL AND INTRAVENOUS ADMINISTRATION OF VARIOUS VASODILATOR AGENTS. Redisch, Walter; de Crinis, Kurt; Steele, J. Murray // Annals of Internal Medicine;Jun61, Vol. 54 Issue 6, p1117 

    Presents a comparative study of vascular responses to the intra-arterial and intravenous administration of various vasodilator agents. Measurement of blood flow to the leg and foot and renal plasma flow; Estimation of cardiac output; Recording of arterial pressure, pulse rate and surface...

  • Significance of Plasma Nitric Oxicle/Endothelial-1 Ratio for Prediction of Coronary Artery Disease. Kurita, Akira; Matsui, Takemi; Ishizuka, Toshiaki; Takase, Bonpei; Satomura, Kimio // Angiology;May/Jun2005, Vol. 56 Issue 3, p259 

    Vascular tone is regulated by vasodilators and vasoconstrictors. Endothelin-1 (ET-1) is the predominant vasoconstrictor peptide that constricts vascular smooth muscle, whereas nitric oxide (NO) is the primary vasodilator peptide that relaxes vascular smooth muscle. In this study, the authors...

  • Fortgeschrittene vasodilatatorische Schockzustände. Luckner, G.; Torgersen, C.; Mayr, V. D.; Jochberger, S.; Wenzel, V.; Hasibeder, W. R.; Dünser, M. W. // Anaesthesist;Feb2009, Vol. 58 Issue 2, p144 

    Arginine vasopressin (AVP) is increasingly being used to treat advanced vasodilatory shock states due to sepsis, systemic inflammatory response syndrome (SIRS) or after cardiac surgery. There are currently no data available on long-term survival. Demographic and clinical data, length of...

  • PAPAVERINE AS AN ANTIARRHYTHMIC AGENT. Whipple, Gerald H. // Angiology;Nov1977, Vol. 28 Issue 11, p737 

    Suggests a chain of events, originating in the clinical experience with papaverine as a vasodilating agent, which may explain the relative lack of attention paid to papaverine as an antiarrhythmic agent. Speculations and suggestions about how papaverine might best be used in antiarrhythmia...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics